Why INOVIO Is Rising In Pre-market?

Shares of INOVIO (INO) surged 6% in pre-market trade on Tuesday as the FDA has lifted the partial clinical hold on INNOVATE phase 3 segment. This provides authorization to proceed for INNOVATE phase 3 segment for its COVID-19 vaccine candidate, INO-4800, in the U.S.

The global phase 3 segment of INNOVATE will evaluate the efficacy of INO-4800 in a two-dose regimen, administered one month apart, in a 2-to-1 randomization in men and non-pregnant women 18 years of age and older. The primary endpoint is virologically confirmed symptomatic COVID-19.

INOVIO noted that the FDA has lifted the partial clinical hold following review of additional non-clinical, clinical, and device information provided by the company.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Home improvement company Lowe's and pet retailer Petco Health and Wellness Co. are set to launch a pilot store-in-store program whereby a total home solution will be offered to customers by bringing home improvement as well as pet care products, services and expertise together under the same roof. Chevron Corporation (CVX) reported fourth quarter profit of $5.1 billion or $2.63 per share, compared to a loss of $665 million or $0.33 per share, previous year. The company's U.S. upstream operations earned $2.97 billion, compared to $101 million, a year ago. The company said the improvement was primarily... While reporting financial results for the fourth quarter on Friday, Colgate-Palmolive Co. (CL) initiated its earnings and sales growth guidance for the full-year 2022. For fiscal 2022, the company now expects earnings per share to grow in double-digit percentage and adjusted earnings per share growth...
Follow RTT